Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
 
Sponsors and Collaborators
Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center

Contact
ClinicalTrials.gov identifier: NCT00702403


Continue Reading

Principal Investigators
Paul Carpenter

Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier
NCT00702403